Scarica l'app Stockscreener
0.9735
20.33%
0.1645
Dopo l'orario di chiusura:
1.01
0.0365
+3.75%
Precedente Chiudi:
$0.809
Aprire:
$0.851
Volume 24 ore:
13.42M
Relative Volume:
2.98
Capitalizzazione di mercato:
$20.77M
Reddito:
$1.44M
Utile/perdita netta:
$-21.34M
Rapporto P/E:
-0.7281
EPS:
-1.3371
Flusso di cassa netto:
$-17.38M
1 W Prestazione:
+101.30%
1M Prestazione:
+81.69%
6M Prestazione:
+23.60%
1 anno Prestazione:
-40.64%
Intervallo 1D:
$0.8425
$1.10
Intervallo di 1 settimana:
$0.4901
$1.17
Portata 52W:
$0.475
$1.9198
Longeveron Inc Stock (LGVN) Company Profile
Nome
Longeveron Inc
Settore
Industria
Telefono
305-302-7158
Indirizzo
1951 NW 7TH AVENUE, MIAMI
Compare LGVN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.9735 | 20.77M | 1.44M | -21.34M | -17.38M | -1.3371 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-06 | Iniziato | ROTH MKM | Buy |
Longeveron Inc Borsa (LGVN) Ultime notizie
Longeveron Hits Milestones in Phase 2b Trial and CEO Transition - timothysykes.com
Longeveron Stock on a Rollercoaster: Clinical Trials and CEO Appointment Fuel Market Interest - StocksToTrade
LGVN Longeveron Inc. (NASDAQ) +20% to $0.97 Mar 13, 2026: earnings, runway - Meyka
Zacks Research Predicts Increased Earnings for Longeveron - Defense World
Longeveron Expands CEO Roster Amid Positive Phase 2 Trial Outcomes - StocksToTrade
Longeveron Announces $30 Million Private Placement Financing - TipRanks
Best Biotech Stocks To Keep An Eye On – March 10th - Defense World
Longeveron closes $15 million financing, extends runway to 4Q26 - Investing.com Australia
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026 - Bitget
Longeveron closes $15 million financing, extends runway to 4Q26 By Investing.com - Investing.com South Africa
Longeveron Announces Closing of Private Placement of up to $30 Million - Bitget
Biotech Longeveron secures $15M, cash runway past 2026 HLHS trial readout - Stock Titan
A $30 Million Reason to Buy Penny Stock Longeveron Today - Barchart.com
Longeveron secures $15M financing with potential for additional $15M tied to trial milestones - MSN
Longeveron secures $15M financing, eyes $15M more on trial results By Investing.com - Investing.com South Africa
Longeveron (LGVN) Shares Surge On $30 Million Private Placement Deal - Benzinga
Longeveron Inc. (LGVN) Stock: Surges 60% as Company Secures $30M Private Placement Funding - parameter.io
LGVN Longeveron (NASDAQ) +97.64% intraday 10 Mar 2026: earnings 12 Mar to watch - Meyka
Longeveron prices 6.01M shares at 52c in private placement - TipRanks
Longeveron jumps 70.7% as investors react to up to $30M private placement financing - Quiver Quantitative
Biotech Stock Longeveron Inc. (NASDAQ: LGVN) Makes Nasdaq Top Gainer List on News - Investorideas.com
Longeveron secures $15M financing, eyes $15M more on trial results - Investing.com India
Longeveron Announces Private Placement of up to $30 Million - Yahoo Finance
LGVN: Company Fortifies Funding - Research Tree
Block Trades: Can Longeveron Inc outperform in the next rally2026 Technicals & Consistent Growth Equity Picks - baoquankhu1.vn
Longeveron Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Longeveron (NASDAQ: LGVN) director resigns, triggering and addressing Nasdaq audit committee issue - Stock Titan
Merger Talk: How cyclical is Longeveron Incs revenue streamLayoff News & Technical Pattern Based Buy Signals - baoquankhu1.vn
Aug Sentiment: Is Longeveron Inc exposed to currency risks2025 Market Outlook & Weekly Breakout Watchlists - baoquankhu1.vn
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them - Cantech Letter
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them - Benzinga
Longeveron Inc. (LGVN) asks shareholders to OK 1:5–1:20 reverse split to meet Nasdaq - Stock Titan
LGVN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LGVN: Trial Results Encouraging - Research Tree
LGVN Should I Buy - Intellectia AI
Longeveron Reports Positive Phase 2b Clinical Trial Results - Intellectia AI
Longeveron Inc. Reports Positive Trial Results for Age-Related Therapy - Intellectia AI
Longeveron Shares Fall After Releasing Phase 2b Data From Age-Related Frailty Study - marketscreener.com
Longeveron publishes phase 2b stem cell trial results in journal - Investing.com
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty In Study - Stocktwits
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study - Stocktwits
Longeveron Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell - Bitget
Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell - The Manila Times
Stem cell therapy helps frailty patients walk farther in Longeveron trial - Stock Titan
Longeveron publishes phase 2b stem cell trial results in journal By Investing.com - Investing.com India
Longeveron launches offering of up to 11.8M shares via warrants and stock units - MSN
Aug Movers: Can Longeveron Inc outperform in the next rallyEarnings Summary Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Q1 Earnings Forecast for Longeveron Issued By Zacks Research - Defense World
Will Longeveron Inc. stock hit new highs in YEARMarket Performance Recap & Intraday High Probability Alerts - mfd.ru
Longeveron (LGVN) Projected to Post Quarterly Earnings on Friday - Defense World
Trade Recap: Does Longeveron Inc offer margin of safetyJuly 2025 Sentiment & Free High Return Stock Watch Alerts - baoquankhu1.vn
Longeveron Inc Azioni (LGVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):